These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6100804)

  • 1. Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part II. Sequential analysis of serum immune complexes and blocking activity in reconstituted mice in relation to tumour biology.
    Tucker DF; Knight RA; Warne PH
    Clin Exp Metastasis; 1983; 1(3):275-87. PubMed ID: 6100804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adoptive T cell immunotherapy of MSV-induced tumours in nude mice. Part I. Biology of tumour regression and recurrence.
    Tucker DF; Knight RA; Warne PH
    Clin Exp Metastasis; 1983; 1(3):261-73. PubMed ID: 6100803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional activity in vivo of effector T cell populations. III. Protection against Moloney murine sarcoma virus (M-MSV)-induced tumors in T cell deficient mice by the adoptive transfer of a M-MSV-specific cytolytic T lymphocyte clone.
    Cerundolo V; Lahaye T; Horvath C; Zanovello P; Collavo D; Engers HD
    Eur J Immunol; 1987 Feb; 17(2):173-8. PubMed ID: 3030766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated arrest and reversal of established visceral metastases in athymic mice.
    Wiltrout RH; Frost P; Morrison MK; Kerbel RS
    Cancer Res; 1979 Oct; 39(10):4034-41. PubMed ID: 476640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth pattern of tumours in mice induced by murine Moloney sarcoma-virus and sarcoma-virus-transformed cells.
    Weiland F; Weiland E; Mussgay M
    Br J Cancer; 1979 Dec; 40(6):932-42. PubMed ID: 230854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of syngeneic effector T cells by soluble tumour antigens.
    Plata F; Levy JP
    Nature; 1974 May; 249(454):271-4. PubMed ID: 4545403
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro demonstration of in situ autologous tumour-cell cytotoxicity in MSV-induced tumours in A/SN mice.
    Becker S; Haskill S
    Br J Cancer; 1981 Mar; 43(3):284-93. PubMed ID: 7053211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.
    Keyaki A; Kuribayashi K; Sakaguchi S; Masuda T; Yamashita J; Handa H; Nakayama E
    Immunology; 1985 Sep; 56(1):141-51. PubMed ID: 3876272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporary inhibition of Moloney-murine sarcoma virus (M-MSV) induced-tumours by adoptive transfer of ricin-treated T-lymphocytes.
    Cerundolo V; Zanovello P; McIntosh D; Fabbris R; Davies AJ; Collavo D
    Br J Cancer; 1987 Apr; 55(4):413-9. PubMed ID: 2437947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pretreatment with immune serum on murine sarcoma virus (Moloney) tumour induction and growth.
    Guiliani F; Casazza AM; Soranzo C; Di Marco A
    Br J Cancer; 1977 Feb; 35(2):190-8. PubMed ID: 189792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing and inhibiting effects of spleen cells from tumour-bearing mice on growth of virus-induced primary sarcoma.
    Kimura H; Aoki T
    Br J Cancer; 1978 Apr; 37(4):553-65. PubMed ID: 206273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cells are crucial for the ability of congenic normal mice to reject highly immunogenic sarcomas induced in nude mice with 3-methylcholanthrene.
    Boesen M; Svane IM; Engel AM; Rygaard J; Thomsen AR; Werdelin O
    Clin Exp Immunol; 2000 Aug; 121(2):210-5. PubMed ID: 10931133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex.
    McDonald TL
    J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific anti-tumor responses of cultured immune spleen cells III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADC) activities.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Oct; 16(4):539-49. PubMed ID: 1080750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F; Jongeneel V; Cerottini JC; Brunner KT
    Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the growth of lymphoid tumours in syngeneic athymic (nude) mice.
    Warner NL; Woodruff MF; Burton RC
    Int J Cancer; 1977 Jul; 20(1):146-55. PubMed ID: 903182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity to murine sarcoma virus induced tumours. IV. Direct cellular cytolysis of 51Cr labelled target cells in vitro and analysis of blocking factors which modulate cytotoxicity.
    Gorczynski RM; Knight RA
    Br J Cancer; 1975 Apr; 31(4):387-404. PubMed ID: 50851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirements for T cells in alloantigen-induced generation of non-T cell-mediated cytotoxicity against syngeneic mouse sarcoma cells.
    Paciucci PA; Macphail S; Bach FH; Zarling JM
    J Immunol; 1980 Jul; 125(1):36-9. PubMed ID: 6155401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among differentiated T-cell subpopulations. V. T-cell dependent mechanism of xenograft rejection and its radioresistant nature.
    Terasaka R; Nomoto K; Himeno K
    Immunology; 1979 Dec; 38(4):773-9. PubMed ID: 316419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induced resistance in normal mice and growth enhancement in tumor-bearing mice by inoculation with syngeneic hybrid cells.
    Dei T; Tachibana T
    J Natl Cancer Inst; 1980 Oct; 65(4):739-49. PubMed ID: 6448309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.